NEW YORK (GenomeWeb News) – Cell Biosciences has sold one of its protein analysis systems to The University of Manchester, the company said today.

The university will use the system in its Stem Cell and Leukemia Proteomics Laboratory to study how phosphoprotein signaling processes in hematopoietic stem calls are different during leukemia.

The platform is a nanofluidic immunoassay system designed to analyze extremely small biological samples, and it can measure cell signaling proteins reproducibly in numbers as small as 25 cells.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.

Oct
10
Sponsored by
PerkinElmer

This online, interactive seminar will answer researchers’ most pressing questions about how to gain outstanding research results from proteomic studies.